Initial report on the expression of GCP-II in neovasculature of gynecologic cancers including primary and metastatic epithelial ovarian cancer suggested high expression of GCP-II at immunohistochemistry in all 46 cases of ovarian cancer assessed (23). Here, FOLH1 is linked to ovarian carcinoma.